Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2025-01-20 DOI:10.1002/ajh.27591

Giovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone, Calogero Vetro, Maria Paola Martelli, Cristina Papayannidis, Ernesta Audisio, Paola Minetto, Carola Riva, Fabio Guolo, Gianluca Martini, Patrizia Zappasodi, Federico Vincenzo, Federica Gigli, Davide Griguolo, Michela Rondoni, Giulia Ciotti, Erika Borlenghi, Nadia Ciccone, Fanny Erika Palumbo, Jacopo Nanni, Daniele Mattei, Massimo Bernardi, Alessandro Cignetti, Chiara Zingaretti, Bernadette Vertogen, Claudio Cerchione, Francesco Lanza, Daniela Cilloni, Lorenzo Brunetti, Raffaele Palmieri, Antonio Curti, Maria Benedetta Giannini, Elisabetta Todisco, AVALON research group, Nicola Fracchiolla, Giovanni Martinelli

{"title":"Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents","authors":"Giovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone, Calogero Vetro, Maria Paola Martelli, Cristina Papayannidis, Ernesta Audisio, Paola Minetto, Carola Riva, Fabio Guolo, Gianluca Martini, Patrizia Zappasodi, Federico Vincenzo, Federica Gigli, Davide Griguolo, Michela Rondoni, Giulia Ciotti, Erika Borlenghi, Nadia Ciccone, Fanny Erika Palumbo, Jacopo Nanni, Daniele Mattei, Massimo Bernardi, Alessandro Cignetti, Chiara Zingaretti, Bernadette Vertogen, Claudio Cerchione, Francesco Lanza, Daniela Cilloni, Lorenzo Brunetti, Raffaele Palmieri, Antonio Curti, Maria Benedetta Giannini, Elisabetta Todisco, AVALON research group, Nicola Fracchiolla, Giovanni Martinelli","doi":"10.1002/ajh.27591","DOIUrl":null,"url":null,"abstract":"<p>Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure>\n </p>","PeriodicalId":7724,"journal":{"name":"American Journal of Hematology","volume":"100 4","pages":"708-711"},"PeriodicalIF":10.1000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.27591","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ajh.27591","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.

Abstract Image

查看原文本刊更多论文

治疗前共病负担对Venetoclax加低甲基化药物患者生存的影响

HMA + VEN患者的生存预期受治疗前合并症负担的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.